NASDAQ:MCRB

Seres Therapeutics Stock News

etoro logo Buy MCRB
*Your capital is at risk
$4.83
+0.0500 (+1.05%)
At Close: Jul 31, 2026
The highest performers of the year are biotechs fighting COVID-19 and cancer. Are they still buys for 2021?
Investors favored coronavirus vaccine work, late-stage trial victories, and genetic sequencing.
Late August spike means share price moves from below $5 to more than $30. Capital raising and Nestle agreement raised $264 million.
Seres has seen +863% upside YTD on the back of positive top-line data in their phase 3 SER-109 study, which helps prove their microbiome hypotheses. Management have strengthened the cash position and
Seres Therapeutics, Inc. (MCRB) CEO Eric Shaff on Q3 2020 Results - Earnings Call Transcript
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced that it has dosed the first patient in its Phase 1b trial evaluating SER-301 for the treatment of active mild
Workers' compensation specialist Applied Underwriters is suing California Insurance Department officials to halt a state plan its says would force its
CDI announces the promotion of Rich Falcone to President, with increased responsibilities in M&A efforts, sales expansion and marketing activities.
Oct 07, 2020 (Market Insight Reports) -- The Global Human Microbiome Therapeutics Market report provides an in-depth analysis of the key market insights, its...
Vedanta Biosciences Awarded Up to $76.9 Million Including $7.4 Million Upfront from BARDA to Advance the Development of VE303
Pas d’assouplissement en vue dans l’obtention du crédit immobilier ! Mi-septembre, le Haut Conseil de Stabilité Financière a confirmé son tour de vis. Les primo-accédants, dont voici quelques
Churchill Downs Incorporated (“CDI”) (Nasdaq: CHDN) released today the following statement regarding the Kentucky Supreme Court ruling on the Exacta system used
CPSI (NASDAQ: CPSI), a healthcare solutions company, and ChartWise Medical Systems Inc. (ChartWise), a computer-assisted clinical document improvement
Acquisition unites two ServiceNow Elite partners to create global digital transformation powerhouse NEW YORK--(BUSINESS WIRE)--#acquisition--Computer Design & Integration LLC ("CDI" or &
Computer Design & Integration LLC (CDI LLC) announces today that it has acquired ServiceNow Elite Partner, P5 Solutions, Inc. (“P5”).
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE